Small Molecules

How Fast Can You Get Your Drug Idea to Market?

No two customers and no two projects are alike. That’s why we’ll take the time to fully understand your needs and customize the right solution for you. Through a systematic, unbiased evaluation of our broad portfolio of differentiated technologies – including asymmetric hydrogenation, hydroformylation and biocatalysis – we work with you to develop the simplest, most cost-effective route for the manufacture of your target material.

No matter where you are in the product development cycle, whether you’re a large, medium or emerging pharmaceutical company, Dowpharma^SM can meet your needs.

Come talk to us. We start by listening.

^SMService mark of The Dow Chemical Company


Capabilities and Services Biocatalysis Biocatalysis Capability Collaborators Enzyme Classes Chemocatalysis Asymmetric Hydrogenation Hydroformylation Trost Allylic Alkylation Complex Synthesis Products Offered Process Development Customer Needs Development Timeline Emerging Pharma Catalyst/Ligand Availability Unnatural Fmoc Amino Acids Unnatural Boc Amino Acids 2-Alkyl Succinates Amines Alcohols Functionalized Cyclopentanes Scaffolds Facilities Literature and Resources Asymmetric Hydrogenation Dowpharma Scientific Publications Hydroformylation Trost Allylic Alkylation Complex Synthesis Biocatalysis Process Development General Publications News Source: Aquapharm Bio-Discovery Ltd Enters a Collaboration Deal with Dowpharma<sup>SM</sup> Contract Manufacturing Services. Dowpharma Relaunches Web Site, Will Make Donation to UNICEF Dow Expands Presence in Pharmaceutical Market, Uniting Existing Offers Under Dowpharma Portfolio Dowpharma Announces New Capabilities in Asymmetric Hydroformylation for Pharmaceutical Applications License of JST Catalyst Technology Expands Dowpharma’s Chiral Commercial Production Capabilities Dowpharma Signs Agreement with Japanese Distributor to Market Pharmaceutical Services in Japan Events Calendar REACH Contact Us		How Fast Can You Get Your Drug Idea to Market? No two customers and no two projects are alike. That’s why we’ll take the time to fully understand your needs and customize the right solution for you. Through a systematic, unbiased evaluation of our broad portfolio of differentiated technologies – including asymmetric hydrogenation, hydroformylation and biocatalysis – we work with you to develop the simplest, most cost-effective route for the manufacture of your target material. No matter where you are in the product development cycle, whether you’re a large, medium or emerging pharmaceutical company, Dowpharma^SM can meet your needs. Come talk to us. We start by listening. ^SMService mark of The Dow Chemical Company
	Dow Home Privacy Statement Internet Disclaimer Accessibility Statement Site Map Copyright © The Dow Chemical Company (1995-2008). All Rights Reserved.